Risk-stratified management of the clinically node-negative neck in early-stage oral squamous cell carcinoma: Elective neck dissection versus watch-and-wait with therapeutic dissection
European Journal of Surgical Oncology · 2026-10 · 52 (10) · 112057
DOI: 10.1016/j.ejso.2026.112057 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Surgical Oncology, 2026-10. Verfasst von Shuchismita Chakraborty und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. Electronic address: shuchismitachakraborty…. Hauptthemen laut MEDLINE: Mouth Neoplasms, Neck Dissection, Watchful Waiting, Squamous Cell Carcinoma of Head and Neck. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To evaluate the optimal management of the clinically node-negative (cN0) neck in early-stage (T1-T2) oral squamous cell carcinoma (OSCC) by comparing initial elective neck dissection (END) versus a Watch & Wait (W&W) approach with therapeutic neck dissection (TND) upon nodal relapse. DATA SOURCES: Studies comparing END versus W&W/TND in T1-T2 cN0 OSCC patients were searched on PubMed till January 2026. PET imaging data were also assessed for nodal staging and surveillance. REVIEW METHODS: Studies comparing END versus W&W/TND in T1-T2 cN0 OSCC patients were searched on PubMed up to January 2026. This comprehensive systematic review without meta-analysis (SWiM) qualitatively synthesized data regarding key outcomes: overall survival (OS), disease-specific survival (DFS), disease-free survival (DFS), nodal recurrence rates, and treatment-related morbidity. Effect estimates from landmark clinical trials and meta-analyses were evaluated to establish a risk-stratified framework. RESULTS: END demonstrated improved 3-year OS (80.0% vs. 67.5%; HR 0.64, P = 0.01) and DFS (69.5% vs. 45.9%; P < 0.001) compared to TND, alongside significantly lower nodal recurrence (15.1% vs. 41.5%; OR 0.25, P < 0.00001). In low-risk patients (T1 tumors, DOI
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. Electronic address: shuchismitachakraborty0@gmail.com.
- Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. Electronic address: debaprasadrath1@gmail.com.
- Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. Electronic address: yashsintovyas@gmail.com.
- Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India; DHR-ICMR Advanced Molecular Oncology Diagnostic Services (DIAMOnDS), Institute of Medical Sciences, Banaras Hind…
Zitieren
APA
Chakraborty, S., Rath, D. P., Vyas, Y., & Pandey, M. (2026). Risk-stratified management of the clinically node-negative neck in early-stage oral squamous cell carcinoma: Elective neck dissection versus watch-and-wait with therapeutic dissection. European Journal of Surgical Oncology, 52(10), 112057. https://doi.org/10.1016/j.ejso.2026.112057
Vancouver
Chakraborty S, Rath DP, Vyas Y, Pandey M. Risk-stratified management of the clinically node-negative neck in early-stage oral squamous cell carcinoma: Elective neck dissection versus watch-and-wait with therapeutic dissection. European Journal of Surgical Oncology. 2026;52(10):112057. doi:10.1016/j.ejso.2026.112057
BibTeX
@article{Chakraborty2026,
author = {Chakraborty, Shuchismita and Rath, Deba P and Vyas, Yash and Pandey, Manoj},
title = {Risk-stratified management of the clinically node-negative neck in early-stage oral squamous cell carcinoma: Elective neck dissection versus watch-and-wait with therapeutic dissection},
journal = {European Journal of Surgical Oncology},
year = {2026},
volume = {52},
number = {10},
pages = {112057},
doi = {10.1016/j.ejso.2026.112057}
}
EUVIMED